OA02.05 CK-101 (RX518), a Third Generation Mutant-Selective Inhibitor of EGFR in NSCLC: Results of an Ongoing Phase I/II Trial

Saved in:
Bibliographic Details
Published inJournal of thoracic oncology Vol. 13; no. 10; p. S323
Main Authors Johnson, M., Karlix, J., Burris, H., Jones, S., Harris, D., O'Byrne, K., Sriuranpong, V., Charoentum, C., Prasongsook, N., Jitpewngam, W., Wirasorn, K., Wang, J., Waqar, S., Oliviero, J., Gorelik, L., Qian, X.
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.10.2018
Online AccessGet full text

Cover

More Information
ISSN:1556-0864
1556-1380
DOI:10.1016/j.jtho.2018.08.242